Patrick D.  Walsh net worth and biography

Patrick Walsh Biography and Net Worth

Director of Landec
Patrick D. Walsh has been appointed as Chairman of the Board of the Company effective 9/8/2020. He is President & Managing Member of Diligence Team, LLC, a consulting practice he founded and is based in Durham, North Carolina. From 2015 to February 2019, Mr. Walsh was the chief executive officer of Avista Pharma, a private equity backed global provider of contract manufacturing, development and analytical testing services to pharmaceutical and biotechnology clients. Prior to Avista, from 2010 to 2014, Mr. Walsh was the chief executive officer of AAIPharma Services Corporation in Wilmington, North Carolina, a private equity backed global provider of contract manufacturing services. Mr. Walsh’s earlier career includes serving as chief executive officer of Kadmus Pharmaceuticals, Inc., in Irvine, California, and serving as president and chief operating officer of publicly-traded Gensia Sicor Pharmaceuticals, Inc. Mr. Walsh currently serves as an independent director of the Board of Directors of Avid Bioservices, a publicly-traded company based in Tustin, California and serves on its nominating committee. He is also an independent director of the Board of Directors of MedPharm LTD, a privately held company in Durham, North Carolina, and serves on its compensation committee. He is also an Operating Partner to healthcare private-equity firm Ampersand Capital, based in Wellesley, Massachusetts. Mr. Walsh is a member of the Board’s Audit and Finance and Compensation Committees. Mr. Walsh is nominated for re-election based on his 30-plus years of experience leading successful pharmaceutical manufacturing and development organizations and his significant prior experience as an independent director.

What is Patrick D. Walsh's net worth?

The estimated net worth of Patrick D. Walsh is at least $0.00 as of April 20th, 2021. Mr. Walsh owns 40,000 shares of Landec stock worth more than $0 as of December 3rd. This net worth approximation does not reflect any other assets that Mr. Walsh may own. Learn More about Patrick D. Walsh's net worth.

How do I contact Patrick D. Walsh?

The corporate mailing address for Mr. Walsh and other Landec executives is 5201 GREAT AMERICA PKWY SUITE 232, SANTA MARIA CA, 93455. Landec can also be reached via phone at (650) 306-1650 and via email at [email protected]. Learn More on Patrick D. Walsh's contact information.

Has Patrick D. Walsh been buying or selling shares of Landec?

Patrick D. Walsh has not been actively trading shares of Landec during the past quarter. Most recently, on Tuesday, April 20th, Patrick D. Walsh bought 10,000 shares of Landec stock. The stock was acquired at an average cost of $11.26 per share, with a total value of $112,600.00. Following the completion of the transaction, the director now directly owns 40,000 shares of the company's stock, valued at $450,400. Learn More on Patrick D. Walsh's trading history.

Who are Landec's active insiders?

Landec's insider roster includes Albert Bolles (CEO), Timothy Burgess (VP), James Hall (VP), John Morberg (CFO), Joshua Schechter (Director), and Patrick Walsh (Director). Learn More on Landec's active insiders.

Patrick D. Walsh Insider Trading History at Landec

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/20/2021Buy10,000$11.26$112,600.0040,000View SEC Filing Icon  
See Full Table

Patrick D. Walsh Buying and Selling Activity at Landec

This chart shows Patrick D Walsh's buying and selling at Landec by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Landec Company Overview

Landec logo
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $8.80
Low: $8.05
High: $9.95

2 Week Range

Now: N/A

Volume

1,739 shs

Average Volume

84,032 shs

Market Capitalization

$259.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1